A Phase II Study of Memantine in the Treatment of Recurrent Glioblastoma.
Phase of Trial: Phase II
Latest Information Update: 11 Dec 2015
At a glance
- Drugs Memantine (Primary)
- Indications Glioblastoma
- Focus Therapeutic Use
- 01 Feb 2013 Planned End Date changed from 1 Nov 2012 to 1 Nov 2013 as reported by ClinicalTrials.gov.
- 11 Aug 2011 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 16 Dec 2010 New trial record